Rycal (ARMGO Pharma)

N/A

Report date: 2025/06/11 10:34:50
NME

Base Information

Drug NameRycal (ARMGO Pharma)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionRyanodine receptor calcium release channel modulators
TargetsRyanodine receptor calcium release channel
Therapy Area/IndicationsSarcopenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRyCarma Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRyCarma Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSarcopenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A